Showing results (3531-3540 of 6,257) with videos related to

Sort By:
Pageof 626
Steroids|February 17, 2001
Vitamin D(3) analogs (MC 1288, KH 1060, EB 1089, GS 1558, and CB 1093): studies on their mechanism of actionP H Mäenpää, S Väisänen, T Jääskeläinen, et al.
Steroids|February 17, 2001
25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesisH S Cross, P Bareis, H Hofer, et al.
Steroids|February 17, 2001
Functions of 1alpha,25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancerC J Narvaez, G Zinser, J Welsh
Steroids|February 17, 2001
Interaction of vitamin D analogs with signaling pathways leading to active cell death in breast cancer cellsG Pirianov, K W Colston
Steroids|February 17, 2001
Metabolites and analogs of 1alpha,25-dihydroxyvitamin D(3): evaluation of actions in boneS Kadiyala, S Nagaba, K Takeuchi, et al.
Steroids|February 17, 2001
Bioactive analogs that simulate subsets of biological activities of 1alpha,25(OH)(2)D(3) in osteoblastsM C Farach-Carson
Steroids|February 17, 2001
The 25(OH)D(3)/1alpha,25(OH)(2)D(3)-24R-hydroxylase: a catabolic or biosynthetic enzyme?H L Henry
Steroids|February 17, 2001
Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D(3): CYP27 in epidermis completes the set of essential vitamin D(3)-hydroxylasesM Schuessler, N Astecker, G Herzig, et al.
Steroids|February 17, 2001
Selective inhibition of vitamin D hydroxylases in human keratinocytesI Schuster, H Egger, D Bikle, et al.
Steroids|February 17, 2001
Metabolism of 1alpha,25-dihydroxyvitamin D(3) in human promyelocytic leukemia (HL-60) cells: in vitro biological activities of the natural metabolites of 1alpha,25-dihydroxyvitamin D(3) produced in HL-60 cellsD S Rao, M J Campbell, H P Koeffler, et al.
Pageof 626